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Inflammation is an important feature in the pathogenesis of most chronic lung diseases. It is characterized by tissue
infiltration with various inflammatory cells, including eosinophils, mast cells, basophils, macrophages, neutrophils,
T- and B-lymphocytes and dendritic cells (1). In the tissue granulocytes release their toxic granule proteins after
being stimulated by soluble mediators released by other inflammatory cells (2). Therefore, it is important to
characterize the intracellular mechanisms regulating the transport of the granule contents in inflammatory cells.
Intracellular vesicle-trac in mammalian cells is mediated by transport vesicles that emerge from donor
compartments and are specifically targeted to acceptor compartments where they deliver their contents after
membrane fusion (3). This trac leads to three types of fusion results: vesicle–intracellular membranes, vesicle–
vesicle or vesicle–plasma membrane. The process leading to fusion of vesicle–plasma membrane is called exocytosis,
and it delivers proteins to the cell surface (receptors e.g. CD11b, CD18) and exports soluble molecules (mediators
e.g. eosinophil cationic protein ECP) from the cell. A number of key proteins involved in regulated exocytosis have
been identified from inflammatory cells. This review is a brief summary of these proteins and it includes recent
results from studies on regulated exocytosis in inflammatory cells.
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Protein secretion from mammalian cells can be either
constitutive or regulated (4,5) (Table 1). While both
pathways exist in most cells, the stimuli required for, and
products released by, regulated exocytosis are specific for
dierentiated cells.
The SNARE-hypothesis
Regulated exocytosis occurs through a pathway consisting
of two steps: Interaction of vesicles with the plasma
membrane (docking) and Ca2+-triggered membrane fusion
[Fig. 1(a)].
Most of the proteins participating in regulated exocytosis
were first biochemically characterized and cloned from
neurons (6,7). The physical contact between the synaptic
vesicles and the plasma membrane is thought to beReceived 18 August 1999 and accepted 1 September 1999.
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0954-6111/00/010010+08 $35?00/0mediated by specific protein–protein interaction. The
SNARE (soluble N-ethylmaleimide sensitive factor attach-
ment receptor)-hypothesis attempts to explain this interac-
tion (8,9). The original SNARE-hypothesis postulates that
vesicular tracking in a mammalian cell involves a unique
vesicle-bound ligand (v-SNARE) that specifically recog-
nizes and interacts with two unique receptor target
molecules (t-SNAREs) found in the plasma membrane. In
synapses a vesicle associated membrane protein called
VAMP-1 (or synaptobrevin-1) has been identified as a v-
SNARE, which interacts with the t-SNAREs syntaxin-1
and SNAP-25 (synaptosomal-associated protein of 25 kDa)
in the plasma membrane. These three proteins form the
SNARE-complex.
The essential role of these SNARE-proteins in regulated
exocytosis has been established by their sensitivity to
specific proteolytic cleavage by the clostridial neurotoxins
Tetanus toxin and Botulin toxin (10).
Synaptotagmin, a vesicular integral membrane protein,
interacts transiently with the SNARE-complex via SNAP-
25 (11). According to the hypothesis an increase of
intracellular Ca2+-concentration triggers the association
of the cytosolic proteins - and -SNAP (soluble NSF
attachment protein, with no homology to SNAP-25) to the
complex by displacing synaptotagmin followed by# 2000 HARCOURT PUBLISHERS LTD
TABLE 1. Presentation of regulated and constitutive secretory pathway
Secretory pathway
Outer signal
requirement Secretory form
Accumulation of
secretory granules
Protein content in
secretory granules
Regulated pathway Yes Rapid Yes High
Constitutive pathway No Constitutive No Low
FIG. 1. (a) Presentation of the order of events leading to
vesicle–plasma membrane fusion in the SNARE-
hypothesis. In the docking step a SNARE-complex
consisting of VAMP, syntaxin and SNAP-25 is formed.
Synaptotagmin binds to the complex and is believed to
work as a Ca2+-sensitive clamp. Upon calcium-binding
synaptotagmin dissociates from the SNARE-complex and
allows - and -SNAP to bind to the complex. The
SNAPs recruit the ATPase NSF which hydrolyses ATP
and thereby dissociates the SNARE-complex. This
dissociation leads to fusion between vesicle and plasma
membrane in which the vesicles release their content.
Following the fusion step the vesicles are recycled. (b)
Schematic presentation showing the localization and
potential protein–protein interactions of the core proteins
involved in regulated exocytosis.
SNARE-PROTEINS IN REGULATED EXOCYTOSE 11recruitment of the ATPase N-ethylmaleimide-sensitive
factor (NSF). Hydrolysis of ATP by NSF results in
disruption of some SNARE-complex protein interactions
before membrane fusion (12,13) and subsequently the
vesicles are recycled (14).Presentation of vesicle targeting
receptors and proteins participating in
regulated exocytosis
The range of the minimal set of proteins that the SNARE
hypothesis identifies as central to the exocytosis is
summarized in Table 2 and Fig. 1(b).
SYNTAXIN-FAMILY
The syntaxin-family includes at least 16 mammalian
members and among these syntaxins 1A-B, 2, 3A-E and 4
participate in exocytosis (15,16). The syntaxin 1A and 1B
are neuron-specific, while the other syntaxins are present in
various tissues. They are integral membrane proteins
with a transmembrane domain at the C-terminal that
anchors the protein in the membrane. The cytoplasmic part
has coiled-coil regions which interact with VAMPs and
SNAP-25 (16).
SNAP-25
SNAP-25 exists in two isoforms, SNAP-25A and SNAP-
25B, that arise by alternative splicing (17). It is mainly
found in neuronal cells, where it is associated with the
plasma membrane via plamitoylation on cysteine residues
at the centre of the protein (18). Both the N-and
C-terminals are located in the cytoplasm and contain
coiled-coil regions which are believed to interact with
syntaxins, VAMPs, synaptotagmin and SNAPs (19).
SNAP-25 has an ubiquitously tissue-expressed homologue,
which is called SNAP-23 (20). It is 59% identical to SNAP-
25 and can, like SNAP-25, interact with both syntaxins and
VAMPs.
VAMP (SYNAPTOBREVIN)-FAMILY
VAMP (synaptobrevin)-family currently has eight de-
scribed members: VAMP-1–8 (12,21). VAMP-1 and
VAMP-2 mainly exist in the brain, whereas the other
VAMP-isoforms are ubiquitously expressed. VAMPs
are integral membrane proteins being anchored to the
membrane of secretory granules by a transmembrane
region adjacent to the C-terminus. The conserved central
domain is proposed to interact with syntaxins and SNAP-
25 (22).
TABLE 2. Properties of mammalian proteins participating in regulated exocytosis
Protein prototype Molecular weight Subcellular localization Putative function References
Syntaxin 35 kDa Plasma-/vesicle membrane
(integral membrane protein)
t-SNARE (15,56,61)
SNAP-25 25 kDa Plasma-/vesicle membrane
(palmitoylated to membrane)
t-SNARE (18,56,62)
SNAP-23 23 kDa Plasma membrane
(palmitoylated to membrane)
t-SNARE (20,63)
VAMP 18 kDa Vesicle membrane
(integral membrane protein)
v-SNARE (12,64–66)
NSF 75 kDa Cytoplasm Disrupts the SNARE-complex (24)
-, -SNAP 35-, 39-kDa Cytoplasm Recruit NSF to the
SNARE-complex
(67)
Synaptotagmin 65 kDa Vesicle membrane
(integral membrane protein)
Ca2+-sensitive clamp (25,68)
Rab3 25 kDa Vesicle membrane
(attached to membrane)
Regulator (28)
Munc-18 67 kDa Plasma membrane
(attached to syntaxin)
Molecular clamp (36)
Hrs-2 115 kDa Plasma membrane
(attached to SNAP-25)
Molecular clamp (34)
Synaptophysin 38 kDa Vesicle membrane
(integral membrane protein
interacting with VAMP)
Molecular clamp (69,70)
For abbrevations see text.
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The NSF/SNAP-complex is built of the ATPase NSF and
the two SNAP-isoforms - and -SNAPs (23). Both NSF
and the SNAP-proteins are cytosolic proteins that are
ubiquitously expressed. They are required in most intracel-
lular vesicular fusion steps. The complex does not exist
freely in the cytoplasm, but is formed upon binding of the
SNAP-proteins to the SNARE-complex. This binding
recruits NSF to the SNARE-complex, which hydrolyses
ATP resulting in disruption of the SNARE-complex (24).
SYNAPTOTAGMIN
Synaptotagmin has at least a dozen mammalian isoforms,
which all are located on vesicles (25). Synaptotagmin I and
II are only expressed in the brain, whereas synaptotagmin
III–XII are detected both in and outside the brain (26). All
synaptotagmins have a N-terminal domain, which is
inserted in the vesicular membrane, and a large cytoplasmic
region with two Ca2+-binding domains (27). Due to the
ability of synaptotagmin to bind calcium, it is believed to
trigger exocytosis. According to this highly debated
postulate, with low intracellular Ca2+-concentration sy-
naptotagmin binds to the SNARE-complex and thus works
as a clamp. But upon an outer Ca2+-signal leading to an
increase in intracellular Ca2+-concentration, synaptotag-
min binds calcium and is displaced from theSNARE-complex, thereby allowing binding of SNAP-
proteins to the SNARE-complex (25).
RAB3 PROTEINS
The rab3 proteins consisting of rab 3A-D proteins are
involved in regulated exocytosis (28). Rab proteins belong
to a large GTP-binding protein superfamily, which exhibits
low sequence identity except for GTP-binding regions
central in the proteins (29). They participate in many steps
of intracellular vesicle-tracking (30).
The four rab3 isoforms are associated with secretory
vesicles in a variety of cell types and dierential expression
of rab3 isoforms has been reported (30,31). They are
associated with the vesicle membrane via geranylation on
C-terminal cysteine residues. The exact role of rab3 proteins
is unknown, but it is assumed that they regulate the
assembly or fidelity of the SNARE proteins, for example
rab3A may have two dierent roles: it eciently docks
vesicles to the plasma membrane (32) and, secondly, it
regulates the eciency of the fusion process (33).
HRS-2, SYNAPTOPHYSIN AND MUNC-18
Hrs-2, synaptophysin and Munc-18 bind to SNAP-25,
VAMP and syntaxin, respectively (34–36). These
three SNARE-interacting proteins may act as molecular
clamps that inhibit vesicle docking until all elements of the
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binding of Hrs-2 to SNAP-25 is inhibited by calcium in the
concentration range that supports exocytosis (34). Hrs-2
may therefore prevent SNAP-25 from interacting with the
other SNARE-proteins until the cell receives an outer
signal, that results in an increase of intracellular Ca2+-
concentration. Hydrolysis of GTP by rab proteins is
expected to cause the release of synaptophysis and Munc-
18 from VAMP and syntaxin, respectively, which allows the
v- and t-SNAREs to interact in the fusion reaction.
SNARE-proteins identified in
inflammatory cells
NEUTROPHILS
Neutrophils play an important role in defence against
infections and in the inflammatory process. They have four
distinct cytoplasmic granules; primary, secondary, tertiary
and secretory granules (37). Upon detection of bacterial
invaders, neutrophils migrate to the infection-site where
they endocytose foreign particles by phagocytosis. Neu-
trophils require cell adhesion molecules on the surface for
diapedesis and migration through tissue. Surface transloca-
tion of secretory vesicles containing adhesion molecules is
regulated by SNARE-complexes (38).
Several SNARE-proteins have been detected in neutro-
phils. Immunoblotting experiments have detected syntaxin-
4, VAMP-2 and SNAP-25 (39,40) (Table 3). These proteins
were present in the plasma membrane and secretory
vesicles. Stimulation of neutrophils induced migration of
VAMP-2 toward the plasma membrane (39). Two isoforms
of SNAP-23 have been detected at the mRNA-level in
neutrophils (41). The localization of these isoforms still has
to be determined in these cells. Using reverse-transcription
polymerase chain reaction (RT-PCR) we have not been
able to detect SNAP-25 in neutrophils. Since RT-PCR isTABLE 3. Presence of SNARE-proteins in inflammatory cells
Protein prototype Neutrophils Mast cells
Syntaxin Syntaxin-3*
Syntaxin-4
Syntaxin-3
Syntaxin-4
SNAP-25 7* 7
SNAP-23 + +
VAMP VAMP-1*
VAMP-2*
VAMP-2
NSF 7 ?
-, -SNAP ? ?
Synaptotagmin 7* +
References (39,41) (44,45)
Explanation of symbols: (7) the protein or its mRNA not dete
data; * own unpublished resulting using RT-PCR on human cemore sensitive than immunoblotting, the presence of
SNAP-25 in neutrophils is questioned. The fact that
SNAP-25 still has been detected in neutrophils by
immunoblotting may be due to use of SNAP-25 antibodies
that crossreact with SNAP-23.
MAST CELLS
Mast cells are highly specialized secretory cells that release
pro-inflammatory mediators such as chemotactic factors
and immunoregulatory cytokines (42). They contain large
populations of secretory granules in their cytoplasm and
undergo exocytosis after stimulation, often within few
minutes (43), implicating their use of regulated exocytosis.
Syntaxin-3, syntaxin-4, VAMP-2 and SNAP-23 have
been identified in mast cells by immunoblotting (44)
(Table 3). The distribution of these four proteins has been
confirmed biochemically (cell fractionation) and morpho-
logically (immunofluorescence microscopy). SNAP-23 and
syntaxin-4 are both plasma membrane proteins, while
syntaxin-3 and VAMP-2 are detected as granular proteins.
Immunofluorescent studies have indicated that SNAP-23 is
relocated from the plasma membrane into the cell interior
in stimulated cells. This relocalization is essential for the
exocytosis as inhibition of this process delays exocytosis
(44). Besides the granule–plasma membrane fusion of
regulated exocytosis, mast cells can also induce fusion
between two intracellular granules. The relocated SNAP-23
may therefore enable formation of SNARE-complexes
between individual granules. SNAP-25 has not been
detected in mast cells by immunoblotting (44).
By immunoblotting, immunofluorescence microscopy
and cell fractionation, synaptotagmin-I has been localized
to secretory granules (45) (Table 3). Synaptotagmin-I may
have a function in exocytosis from mast cells, since
transfection of mast cells with the synaptotagmin-I cDNA
influenced the Ca2+-dependent exocytosis (45).Macrophages Eosinophils Basophils
Syntaxin-2
Syntaxin-3
Syntaxin-4
Syntaxin-3* ?
? 7* 7
? +* +*
VAMP-related VAMP-1*
VAMP-2*
?
+ ? ?
-SNAP ? ?
? 7* ?
(47–49) (52)
cted; (+) the protein or its mRNA detected; (?) no available
lls. For abbreviations see text.
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Macrophages play a primary role in immune defence by
phagocytosis of pathogens. During phagocytosis a phago-
some is formed, which matures by specific fusion with
intracellular vesicles. In addition to phagocytosis the
macrophages also have a proinflammatory function by
rapidly releasing cytokines (46).
Syntaxin-2, syntaxin-3 and syntaxin-4 have been identi-
fied in both the phagosomal and plasma membranes by
immunoblotting (47) (Table 3). VAMP has also been
detected in macrophages by immunoblotting (48) (Table 3).
This protein was identified due to its recognition of VAMP
antibodies in immunoblotting experiments and its sensitiv-
ity to Tetanus toxin. In addition NSF and -SNAP have
been identified on phagosomes containing a living intracel-
lular pathogen Listeria (49) (Table 3). This implicates that
SNARE complex proteins participate in endocytosis in
macrophages as well.
EOSINOPHILS AND BASOPHILS
Both eosinophils and basophils release toxic granule
proteins by degranulation, which plays a central role in
host defence and in the pathophysiology of diseases
associated with eosinophils and basophils. The degranula-
tion process in both eosinophils and basophils is believed to
happen through regulated exocytosis, since the process is
very rapid (50,51). By RT-PCR we have identified syntaxin-
3A, VAMP-1, VAMP-2 and SNAP-23 in human
eosinophils, whereas SNAP-25 and synaptotagmin were
not expressed in these cells (Table 3). In addition,
functional experiments showed that pretreatment of eosi-
nophils with Tetanus toxin, which cleaves VAMP-2,
inhibited eosinophil degranulation (52). This indicates that
VAMP-2 has a functional role in eosinophil degranulation.
In basopohils only SNAP-23 has been detected (own
unpublished results).
T- AND B-LYMPHOCYTES AND DENDRITIC
CELLS
Both the lymphocytes and dendritic cells are part of
the immune defence of mammals against foreign
invaders. Dendritic cells present antigens to the T-cells,
which by releasing cytokines attract the other inflam-
matory cells and thereby cause inflammation. In the
inflammatory process, the B-lymphocytes release antibo-
dies. By binding to the eector cells, the antibodies activate
these cells (53).
Exocytosis from lymphocytes and dendritic cells
may happen through regulated exocytosis. There is
circumstantial evidence that some T-cells release preformed
cytokines upon stimulation via the T-cell receptor (N.
Ødum, personal communications). So far no proteins
participating in regulated exocytosis have been identified
in these cells.New insights regarding SNAREs in
regulated exocytosis
Interest in the SNARE-hypothesis has been great because it
may explain all intracellular vesicular fusion events. Many
of the protein–protein interactions postulated by the
SNARE-hypothesis have been confirmed over the past
few years. However, recent work has questioned some of
the postulates of the SNARE-hypothesis. One question
concerns the specificity of vesicle trac. Is it regulated by
the SNARE-complex formation alone, or do other reg-
ulatory mechanisms exist?
The essential postulate of the original SNARE-hypoth-
esis was that a v-SNARE interacted with two t-SNAREs to
determine target specificity in membrane tracking. How-
ever, now it appears that the SNARE-proteins participate
in the formation of several dierent SNARE complexes and
therefore are able to pair with more than one set of partners
(28,54). Therefore, additional regulatory proteins may
contribute to the specificity. In addition, no prevention of
vesicle docking was seen in Drosophila expressing deficient
syntaxin (55). The finding that both t-SNAREs, SNAP-25
and syntaxin, are present on vesicles, has questioned the
docking process described by the SNARE-hypothesis even
more (56). Recently, calcium was found to induce fusion
without formation of the SNARE-complex. When the
SNARE-complex was disrupted, vesicles were still able to
bind to the plasma membrane and retain full ability for
Ca2+-triggered exocytosis (57). Thus several factors other
than v- and t-SNAREs determine the specificity of vesicle-
target membrane fusion.
Another question of the original SNARE-hypothesis is:
when does NSF/SNAP enter the process of vesicle docking
and fusion?
According to the original SNARE-hypothesis NSF and
SNAP act on the SNARE-complex at the point of vesicle
docking and immediately before fusion. However, new data
indicate that NSF and SNAP act on SNARE complexes on
undocked vesicles. NSF and -SNAP have been purified
from secretory vesicles (58), and it has been shown that they
disassemble the SNARE-complex on the vesicles (59). Since
NSF/SNAP have been shown to change the conformation
of syntaxin (60), it is possible that NSF/SNAP, by binding
to the SNARE complex on the vesicles, can modify the
conformation of the SNAREs and thereby prepare vesicles
for the following round of docking and fusion. In addition,
it could be that NSF/SNAP also could prepare t-SNAREs
located on the plasma membrane for vesicle docking (60).
The original SNARE-hypothesis can explain many
intracellular events, but there are still some unsolved
questions. Therefore, the SNARE-complex hypothesis has
to be reassessed to give a more clear picture of the
molecular machinery controlling regulated exocytosis.
Perspectives
Attention has to be paid to prevention of the inflammatory
cascade before it gets established. By preventing the release
of soluble mediators from the inflammatory cells, several
SNARE-PROTEINS IN REGULATED EXOCYTOSE 15toxic eects caused by these cells can be inhibited. Here it is
important to understand the SNARE-machinery in inflam-
matory cells. The proteins implicated in the regulated
exocytosis from the inflammatory cells can be a whole new
set of promising targets for drugs. Future challenges are to
elucidate the actual functional role played by proteins
mediating exocytosis in the inflammatory cells. This
exciting field of future research will hopefully provide us
with new strategies for therapy.
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